Ms Sharonmoyee Goswami > Cravath, Swaine & Moore LLP > New York, United States > Lawyer Profile

Cravath, Swaine & Moore LLP
Two Manhattan West
375 Ninth Avenue
New York 10001
United States
Sharonmoyee Goswami photo

Work Department

Litigation.

Position

Sharonmoyee Goswami focuses her practice on intellectual property, antitrust and other litigation involving complex scientific issues. She has extensive experience representing companies and individuals in all stages of litigation, from pre‑complaint investigation through appeal, and routinely practices before the Federal Circuit and Patent Trial and Appeal Board (PTAB).

Ms. Goswami draws upon her expertise to help companies address legal issues that arise during product development and commercialization, including successfully bringing lifesaving therapies to patients. She regularly leads patent infringement litigation across various industries—including medical devices, pharmaceuticals, technology and financial services—and has significant experience in intellectual property strategy and management.

Lawyer Rankings

United States > Intellectual property > Patents: litigation (full coverage)

With expertise in a broad range of technologies and industries, Cravath, Swaine & Moore LLP represents clients in intellectual property disputes and commercial transactions. The group’s breadth of technical knowledge allows it to act for clients in sectors such as consumer products, telecoms and media and entertainment, and it has specialist capabilities litigating patent disputes in the pharmaceuticals, medical devices and biotech fields. Operating out of New York, the IP practice is co-chaired by Keith Hummel, a patent attorney whose patent litigation practice spans a variety of industries, and David Kappos. Another key practitioner is Sharonmoyee Goswami, who focuses on intellectual property, antitrust and litigation relating to science and tech and is experienced acting for clients in multiple patent litigation venues, including the International Trade Commission and the Patent Trial and Appeal Board.